Breakthrough Cancer Pain
📧 Sign up to get email alerts when something new happens for Breakthrough Cancer Pain.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-06-12Clinical Trial Update: Effectiveness and Tolerance of Inhaled Fentanyl Aerosol (25µg/Dose) in Chinese Patients With BTcP [Phase 2]
A Phase 2 trial in Chinese patients with Breakthrough Cancer Pain evaluated the effectiveness and tolerability of inhaled fentanyl aerosol a…
-
CLINICAL_TRIALS trial_result · 2021-07-28Clinical Trial Update: Inhaled Cannabinoids Versus Immediate-release Oral Opioids for the Management of Breakthrough Cancer Pain [Phase 2]
Phase 2 clinical trial evaluating inhaled cannabinoids versus immediate-release oral opioids for breakthrough cancer pain.
-
CLINICAL_TRIALS trial_result · 2021-02-02Clinical Trial Update: Effectiveness and Tolerance of Inhaled Fentanyl Aerosol (25µg/Dose) in Chinese Patients With Breakthrough Cancer Pain [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating the effectiveness and tolerance of an inhaled fentanyl aerosol (25 µg per dose) in Chinese patients wi…
-
CLINICAL_TRIALS trial_result · 2016-04-14Clinical Trial Update: Prospective Longitudinal Observational Study to Evaluate the Clinical Characteristics and Opioids Treatments in Patients With Breakthrough Cancer Pain
A prospective longitudinal observational study evaluating clinical characteristics and opioid treatments for breakthrough cancer pain in can…
-
CLINICAL_TRIALS trial_result · 2013-07-11Clinical Trial Update: Patient Satisfaction and Quality of Life Impact - PecFent®
This clinical trial update discusses patient satisfaction and quality-of-life impacts in people using PecFent for breakthrough cancer pain.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-03-21Clinical Trial Update: A Clinical Trial to Assess the Clinical Benefit of SSR411298 as Adjunctive Treatment for Persistent Cancer Pain [Phase 2]
A Phase 2 clinical trial evaluating SSR411298 as an adjunctive treatment for persistent cancer pain has been terminated.
-
CLINICAL_TRIALS trial_result · 2009-01-14Clinical Trial Update: Safety of Fentanyl TAIFUN Treatment [Phase 3]
Phase 3 trial update assessing the safety of fentanyl TAIFUN for breakthrough cancer pain.